$27.440
-0.414 (-1.51%)收盘时
价格预测
在 App 中打开以解锁更长周期的预测。
Loading chart…
该买入 Braveheart Bio, Inc. 股票吗？
Braveheart Bio, Inc. is a good buy right now, especially considering the recent insider purchases and strong IPO performance. The stock closed at $27.44, which is significantly higher than the IPO price of $18, reflecting a $12 gain per share. Furthermore, the company's forward P/E is 0, indicating potential for future earnings growth as it progresses in its clinical trials.
BRVE 股价于 Friday 收于 $27.44，此前下跌 -1.51%
Braveheart Bio, Inc. (BRVE) last closed at $27.44, losing -1.51%. These facts feed the 1-day and 1-week BRVE price prediction above.
预测驱动因素
Braveheart Bio, Inc.（BRVE）的预测驱动因素综合了相似的图表形态、季节性与移动平均线。
Seasonality
Positive
Bullish
BRVE 季节性分析
Loading chart…
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。